Doctors Praise Moderna and Merck Cancer Vaccine
Top doctors say a new shot from Moderna and Merck helps skin cancer patients stay healthy after surgery.
Skin cancer patients have new hope today. Doctors cheer fresh data from Moderna and Merck. The two drugmakers tested a custom shot on people with melanoma.
Six top cancer specialists reviewed the study results. They call the numbers a major win for patients. People took the vaccine after surgery to remove tumors. The treatment helped stop the cancer from returning.
Wall Street traders showed little excitement over the news. Even so, medical experts see true progress. They believe this shot changes the future of cancer care.
Medical science moves forward one breakthrough at a time. This success shows that personalized treatments work. Watch these companies as the trials expand into new stages.
Source: CNBC
More from Biotech
